Despite our encouraging first results, our vaccines seemed to induce a pro-tumoral effect in PDAC tumor-bearing mice, especially in the long-term, similarly to what it has been described for another K-Ras vaccine that favored tumor growth in skin cancer (in this case with a G12R mutation) (30). This evidence concerns the gene KRAS and skin neoplasm.